NCT00193570View on ClinicalTrials.gov

Topotecan in Combination With Docetaxel in Refractory and/or Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

August 31, 2004

Study Completion Date

January 31, 2009

Conditions
Cancer
Interventions
DRUG

Topotecan

DRUG

Docetaxel

Sponsors
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

collaborator

Genentech, Inc.

INDUSTRY

lead

SCRI Development Innovations, LLC

OTHER